CiceroDiagnostics
Healthcare Services · Nevada, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2538 Anthem Village Dr Ste 105, Henderso...Website
www.cicerodx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
2
1
About CiceroDiagnostics
Cicero Diagnostics is a women's health care company specializing in early endometriosis detection and infertility solutions. Their flagship product, ReceptivaDx, offers clinically proven testing services that help fertility centers identify underlying issues related to unexplained infertility, failed implantation, and recurrent pregnancy loss. With over 300 fertility centers utilizing their services globally, Cicero Diagnostics aims to expedite patient referrals and treatment plans for women facing chronic pain and fertility challenges. The company is committed to advancing clinical assays for women's diseases and continues to engage in research to enhance their testing mechanisms.Explore more
CiceroDiagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CiceroDiagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
CiceroDiagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on CiceroDiagnostics recently announced quarterly report
Check out if CiceroDiagnostics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if CiceroDiagnostics has recently received funding, and reach out quickly before it becomes old news!
Click to see if CiceroDiagnostics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CiceroDiagnostics
Funding: Get notified immidiatlly once CiceroDiagnostics has new funding data
Product Launch: Get notified when CiceroDiagnostics launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined CiceroDiagnostics as Masked Content
Find more new buyers
Compare Similar Companies to CiceroDiagnostics
Compare insights from companies similar to CiceroDiagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CiceroDiagnostics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
CiceroDiagnostics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about CiceroDiagnostics.
CiceroDiagnostics Tech Stack
A closer look at the technologies used by CiceroDiagnostics
CiceroDiagnostics News & Media
Cicero Diagnostics reaches 10,000-patient milestone with its ReceptivaDx™ Test
HENDERSON, Nev.--(BUSINESS WIRE)-- #endometriosis--Cicero Diagnostics reaches 10,000-patient milestone with its ReceptivaDx™ TestCicero Diagnostics to Partner with Mediaplanet a Second Time in a...
ReceptivaDX detects inflammation likely caused by endometriosis that may be contributing to infertility or recurrent pregnancy loss (PRWeb September 16, 2021) Read the full story at https://www.prweb.com/releases/cicero_diagnostics_to_partner_with_mediaplanet_a_second_time_in_a_campaign_to_educate_women_contemplating_ivf_about_its_receptivadx_test/prweb18197679.htmCicero Diagnostics Introduces Fertility App for ReceptivaDx
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)-- #endometriosis--As more women seek information on ReceptivaDx for unexplained infertility and pregnancy loss, new app adds value for physician staff and patients.Cicero Diagnostics Hits Record Growth For First Quarter 2021
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)-- #endometriosis--Cicero Diagnostics Hits Record Growth For First Quarter 2021; 700+ Reproductive Endocrinologists, 80% of US fertility sites now access ReceptivaDx™
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CiceroDiagnostics
Sign Up For FreeTo access detailed company insights
Cicero Diagnostics is a women's health care company specializing in early endometriosis detection and infertility solutions. Their flagship product, ReceptivaDx, offers clinically proven testing services that help fertility centers identify underlying issues related to unexplained infertility, failed implantation, and recurrent pregnancy loss. With... Read More
